A retrospective cohort study of mycophenolate mofetil (MMF) in the treatment of steroid-resistant nephrotic syndrome (SRNS)
Latest Information Update: 04 Feb 2019
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Nephrotic syndrome
- Focus Pharmacokinetics
Most Recent Events
- 04 Feb 2019 New trial record
- 12 Dec 2018 Results evaluating apparent mycophenolic acid clearance (n=10) were published in the Clinical Nephrology.